Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

Grampsas Wins National Biotech Award
Oct 27 1998
(WASHINGTON, D.C., October 27, 1998). . . Colorado State Rep.Tony Grampsas (R) has been named the "Outstanding State Legislator of the Year" by the...
Biotech Reporters: MARK YOUR CALENDAR NOW!
Oct 27 1998
(WASHINGTON, D.C., October 27, 1998). . .The Biotechnology Industry Organization (BIO), the largest association of biotechnology companies, state...
BIO Supports Capital Gains Incentive Bill Introduced by Rep. Dunn
Oct 2 1998
(WASHINGTON, D.C., October 2, 1998)...The Biotechnology Industry Organization (BIO) today praised U.S. Rep. Jennifer Dunn (R-Bellevue) of Washington for...
Biotech Industry Responds To Stock Market Fluctuations
Sep 2 1998
(WASHINGTON, DC, September 2, 1998)...Carl B.Feldbaum, president of the Biotechnology IndustryOrganization (BIO), issued the following statement inresponse...
Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, GENETICALLY MODIFIED FOODS
Aug 12 1998
This week's intense and global publicity given to Dr. Pusztai's work and its implications has led to the Rowett Research Institute's decision to...
BIO Welcomes Verification of Dolly's Cloning, Stands by Ban on Human Cloning
Jul 22 1998
WASHINGTON, D.C. (July 22, 1998) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today issued the following statement on the...
Seattle Selected For Biotech Meeting
Jul 6 1998
(WASHINGTON, D.C., July 6, 1998)...The Biotechnology Industry Organization (BIO), the largest association of biotechnology companies, state associations and...
Biotech Forum To Focus On Cancer Breakthroughs
May 15 1998
Recent successes in cancer research have turned the spotlight on the war against cancer and biotechnology's role in this fight. Leading biotechnology...
Growing Scope, Impact of Biotechnology Showcased at BIO'98
May 15 1998
WASHINGTON, D.C. (May 15, 1998) - "Whether it is new human vaccines delivered by eating common fruits and vegetables, gene therapies for life...
BIO Supports Doubling NIH Budget over Five Years
Mar 20 1998
WASHINGTON, D.C. (March 19, 1998) In supporting a 15 percent increase for the FY 1999 budget of the National Institutes of Health (NIH) and doubling the...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...